Gainers
- Agile Therapeutics AGRX shares rose 8.1% to $0.37 during Monday's after-market session. The market value of their outstanding shares is at $44.7 million.
- Iterum Therapeutics ITRM shares moved upwards by 7.06% to $0.42. The company's market cap stands at $76.7 million.
- Cellectar Biosciences CLRB shares moved upwards by 5.33% to $0.59. The market value of their outstanding shares is at $36.0 million.
- Codex DNA DNAY shares moved upwards by 4.35% to $9.35. The company's market cap stands at $274.0 million.
- Viking Therapeutics VKTX stock increased by 4.13% to $3.78. The market value of their outstanding shares is at $295.7 million.
- Axsome Therapeutics AXSM stock rose 3.96% to $31.73. The company's market cap stands at $1.1 billion.
Losers
- Nuvectis Pharma NVCT stock decreased by 5.7% to $7.5 during Monday's after-market session. This security traded at a volume of 184.8K shares come close, making up 25.0% of its average volume over the last 100 days. The company's market cap stands at $88.6 million.
- PolarityTE PTE shares fell 5.24% to $0.46. The company's market cap stands at $37.6 million.
- InVivo Therapeutics Hldg NVIV stock fell 4.74% to $0.35. The company's market cap stands at $11.9 million.
- Hims & Hers Health HIMS stock declined by 3.54% to $4.5. Hims & Hers Health's trading volume hit 59.6K shares by close, accounting for 2.2% of its average volume over the last 100 days. The company's market cap stands at $917.6 million.
- Phio Pharmaceuticals PHIO stock decreased by 3.31% to $0.87. The company's market cap stands at $11.7 million.
- Recursion Pharmaceuticals RXRX stock declined by 2.67% to $11.32. The company's market cap stands at $1.9 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in